Description
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of antibody therapeutics.
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $5,950,000 at start, $6,325,000 after amendment #1 (+$375,000).
- #02022-11-01$5,950,000
- #12024-03-27$6,325,000+$375,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2022-11-01(start date) | $5,950,000 | — | Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity… |
| #1 amendment | 2024-03-27 | $6,325,000 | +$375,000 | Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity… |
Related records · 9
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 838509446)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2023-2024-Q1-819720 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream3- Attraction | $225,000,000 | FY2022 |
| 033-2020-2021-Q1-512889 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream 2 - Growth | $175,631,000 | FY2021 |
| GC-WD-DEO-2019-2020-Q2-114 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Regional Economic Growth through Innovation | $5,000,000 | FY2020 |
| 172-2018-2019-Q4-921989 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $2,617,300 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2022-2023-Q4-1002444 · retrieved 2026-11-14.